MindWalk Holdings (HYFT) Net Income (QoQ) (2021 - 2026)
Powered by 
Analysis
MindWalk Holdings (HYFT) Net Income (QoQ) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | MindWalk Holdings | 61.22 Mn | 52.95 Mn | 1.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -188.13% |
| Jan 31, 2026 | -56.89% |
| Oct 31, 2025 | 405.05% |
| Jul 31, 2025 | -241.81% |
| Apr 30, 2025 | -89.98% |
| Jan 31, 2025 | 710.90% |
| Oct 31, 2024 | -35.99% |
| Jul 31, 2024 | -77.51% |
| Apr 30, 2024 | 555.62% |
| Jan 31, 2024 | 11.41% |
| Oct 31, 2023 | -30.52% |
| Jul 31, 2023 | -32.48% |
| Apr 30, 2023 | 214.23% |
| Jan 31, 2023 | 40.04% |
| Oct 31, 2022 | 26.38% |
| Jul 31, 2022 | -79.38% |
| Apr 30, 2022 | -17.49% |
| Jan 31, 2022 | 8.06% |
| Oct 31, 2021 | -30.46% |
| Jul 31, 2021 | 9.10% |